Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure?

Human Reproduction

Volumn 17, Issue 4, 2002, Pages 1106-1111

  Nikolaou, D ^a,b   Lavery, S ^a   Turner, C ^a   Margara, R ^a   Trew, G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ABERDEEN MATERNITY HOSPITAL   (United Kingdom)

Author keywords

IVF; Menopause; Ovarian failure; Ovarian reserve; Poor response

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; SEX HORMONE;

ADULT; AGE; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FISHER EXACT TEST; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

FALLOPIA; MARTES PENNANTI;

EID: 0036113230     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.4.1106     Document Type: Article

References (58)

1. Variations in the reporting of menstrual histories
2. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women
3. Aneuploidy 16 in human embryos increases significantly with maternal age
4. Oocyte loss and the perimenopause
5. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles
6. Low and high responders at what levels of serum estradiol do things start to get fuzzy?
7. Diminished ovarian reserve in normal cycling women is a predictor of unfavourable lipid levels and increased cardiovascular risk
8. Is the age of menopause determined in utero?
9. Fetal growth retardation as a cause of impaired ovarian development
10. The role of genetic factors in age at natural menopause
11. Intercommunication between mammalian oocytes and companion somatic cells
12. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause
13. Non response to ovarian stimulation in normogonadotrophic, normogonadal women: A clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels
14. Ovarian reserve test with gonadotrophin-releasing hormone agonist Buserelin: Correlation with in-vitro fertilization outcome
15. Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility centre population
16. Inhibin-B: The physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening
17. A prospective study of prognostic factors in in-vitro fertilization and embryo transfer
18. Inhibin and oestradiol responses to ovarian hyperstimulation: Effects of age and predictive value for in vitro fertilization outcome
19. Comparison of 'poor' responders with 'good responders' using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization
20. A rational approach to the management of low responders in in-vitro fertilization: Opinion
21. Assisted conception following poor ovarian response to gonadotrophin stimulation
22. Could ovarian infection impair ovarian response to gonadotrophin stimulation
23. Significance of basal follicle stimulating hormone in women with one ovary in a program of in vitro fertilization
24. Measurement of ovarian volume by transvaginal sonography before human menopausal gonadotrophin superovulation for in-vitro fertilization can predict poor response
25. Follicular density in ovarian biopsy of infertile women: A novel method to assess ovarian reserve
26. Effect of salpingectomy on ovarian response to superovulation in an in-vitro fertilization-embryo transfer program
27. One thousand initiated cycles of in-vitro fertilization in women ≥40 years of age
28. Age-related decline in fertility: A link to degenerative oocytes?
29. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test
30. Embryo morphology, developmental rates and maternal age are correlated with chromosome abnormalities
31. The impact of ovarian cystectomy on ovarian response to stimulation during in vitro fertilization cycles
32. Prognostic assessment of female fecundity
33. Premature ovarian failure
34. The impact of endocrine disrupters on the female reproductive system
35. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation
36. Effect of maternal age and number of in vitro fertilizaton procedures on pregnancy outcome
37. Ovulation induction in women age 40 and older: The importance of basal follicle-stimulating hormone level and chronological age
38. Day 4 estradiol levels predict pregnancy success in women undergoing controlled ovarian hyperstimulation for IVF
39. Simultaneous evaluation of basal follicle-stimulating hormone and 17-β-estradiol response to gonadotropin-releasing hormone analogue stimulation: An improved predictor of ovarian reserve
40. Prognostic assessment of ovarian reserve
41. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vigtro fertilization outcome
42. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population
43. Moving toward an earlier and better understanding of perimenopause
44. Proliferative index of human luteinized granulosa cells varies as a function of ovarian reserve
45. Apoptosis as a function of ovarian reserve in women undergoing in-vitro fertilization
46. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
47. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone
48. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by clomiphene citrate challenge test
49. The detection of diminished ovarian reserve in infertile women
50. Environmental toxicants and female reproduction
51. Age and basal stimulating hormone as predictors of in vitro fertilization outcome
52. An analysis of factors influencing the establishment of a clinical pregnancy in an ultrasound-based ambulatory in vitro fertilization program
53. The idiopathic forms of premature menopause and early menopause show the same genetic pattern
54. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age
55. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values?
56. Fertility prognosis in IVF treatment of patients with cancelled cycles
57. The meiotic competence of in-vitro matured human oocytes is influenced by donor age: Evidence that folliculogenesis is compromised in the reproductively aged ovary
58. Endometriosis and ovulatory disorder: Reduced fertilization in vitro compared with tubal and unexplained infertility